Use of ustekinumab after other biological therapies in moderate-severe psoriasis: Real long-term data Manuel David Gil-Sierra; Esmeralda Ríos-Sánchez; María del Pilar Briceño-Casado;

Patient benefit as a goal of humanization Manuel David Gil-Sierra; María del Pilar Briceño-Casado; Eduardo López-Briz;

Concordance between expectations and preferences of patients and evaluation criteria of the European Medicines Agency Manuel David Gil-Sierra; María del Pilar Briceño-Casado; Ángel Jesús Arias-Arias; Santiago Martín-Rodríguez;